About RNAtopia

RNAtopia was founded on August 1st, 2025—a date chosen with intention. In molecular biology, AUG marks the start codon, the signal to begin translation. For us, it symbolizes the beginning of a new era in RNA therapeutics.

At RNAtopia, our mission is to revolutionize human health through cutting-edge self-amplifying RNA (saRNA) technology. We are committed to overcoming the limitations of conventional mRNA therapies by delivering scalable, durable, and precision-engineered solutions for a wide range of medical challenges.

Our saRNA platform enables:

• Bimonthly injectable GLP-1-like peptides with enhanced stability and reduced dosing frequency
• Single or multi-component vaccines for infectious diseases and beyond
• Genetic medicines that are modular, durable, and administered bimonthly
• Smart bomb therapeutics—targeted, multi-component constructs designed to selectively destroy cancer cells

RNAtopia is building a future where RNA isn’t just a molecule—it’s a modular engine for curing disease, restoring health, and transforming lives.